Akari therapeutics to present at live! with webull corporate connect: virtual biotech investment webinar

Boston and london, may 22, 2025 (globe newswire) -- akari therapeutics, plc (nasdaq: aktx), an oncology biotechnology company developing novel payload antibody drug conjugates (adcs), today announced that abizer gaslightwala, president and ceo of akari, will present and discuss recent corporate events at live! with webull corporate connect: virtual biotech investment webinar on thursday, may 29, 2025 at 2:00 pm et.
LIVE Ratings Summary
LIVE Quant Ranking